A Chiral Hydrogel Accelerates Wound Healing via the Lactylation of Ring Finger Protein 123
ACS Applied Materials & Interfaces · 2026-02-04 · 18 (4) · 6498-6513
DOI: 10.1021/acsami.5c21101 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published online on 2026-01-23. Written by Ruizhe He and 10 co-authors. Institution: Department of Burns and Plastic Surgery & Department of Plastic Surgery and Reconstructive Surgery, Shanghai Ninth People's Hospital and Institute of…. Major MEDLINE topics: Wound Healing, Hydrogels, Ubiquitin-Protein Ligases. Cited 2 times so far (Crossref); 46 references. Funded by: National Key Research and Development Program of China, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Topics: Wundversorgung
Abstract (original language)
Chronic wounds, characterized by delayed healing and persistent inflammation, represent a major clinical burden with limited effective therapies. Inspired by the stereoselective interactions in biological systems, we developed an L-chiral hydrogel composed of self-assembled helical nanofibers from l-tryptophan derivatives, which preferentially enriches lactate to promote wound repair. Compared to D-chiral and racemic hydrogels, the L-chiral hydrogel significantly accelerated wound closure in rat models, achieving nearly 90% healing by day 14 and reducing healing time to 16-17 days. Transcriptomic and metabolomic analyses revealed enhanced wound response pathways and elevated lactate levels in the L-chiral group. Mechanistically, enriched lactate induced K57 lactylation of Ring Finger Protein 123 (RNF123), mediated by AARS1, altering RNF123 conformation and weakening its binding to UBAC1. This modification enhanced ubiquitination and processing of NF-κB p105 into p50, inhibiting the NF-κB pathway and promoting angiogenesis via enhanced endothelial cell migration, tube formation, and sprouting. Rescue experiments with lactate inhibitor Oxamate and exogenous lactate confirmed the lactate-dependent mechanism. This study not only demonstrates a drug-free chiral biomaterial for efficient wound healing but also unveils the molecular role of lactate-mediated lactylation in mechanoregulating inflammation and vascularization, offering new insights for regenerative medicine.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Burns and Plastic Surgery & Department of Plastic Surgery and Reconstructive Surgery, Shanghai Ninth People's Hospital and Institute of Traumatic Medicine, Shanghai Jiao Tong University School of Medicine,…
- State Key Lab of Metal Matrix Composites, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Materials Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID profiles: Laiben Gao, Xiaoqiu Dou
Funding
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Ninth People?s Hospital of Shanghai Jiao Tong University School of Medicine
- School of Medicine, Shanghai Jiaotong University
Cite
APA
He, R., Liu, T., Xing, C., Sun, M., Geng, L., Gao, L., Dou, X., Ni, T., Xu, P., Peng, Y., & Fang, Y. (2026). A Chiral Hydrogel Accelerates Wound Healing via the Lactylation of Ring Finger Protein 123. ACS Applied Materials & Interfaces, 18(4), 6498-6513. https://doi.org/10.1021/acsami.5c21101
Vancouver
He R, Liu T, Xing C, Sun M, Geng L, Gao L, et al. A Chiral Hydrogel Accelerates Wound Healing via the Lactylation of Ring Finger Protein 123. ACS Applied Materials & Interfaces. 2026;18(4):6498-6513. doi:10.1021/acsami.5c21101
BibTeX
@article{He2026,
author = {He, Ruizhe and Liu, Tiantian and Xing, Chao and Sun, Mengzhe and Geng, Lele and Gao, Laiben and Dou, Xiaoqiu and Ni, Tao and Xu, Peng and Peng, Yinbo and Fang, Yong},
title = {A Chiral Hydrogel Accelerates Wound Healing via the Lactylation of Ring Finger Protein 123},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {4},
pages = {6498--6513},
doi = {10.1021/acsami.5c21101}
}
EUVIMED